Amphipathic cell-penetrating peptide-based molecular transporters: A balanced approach for membrane penetration.
The intracellular delivery of therapeutic biomacromolecules remains a fundamental challenge in modern drug development, primarily because the plasma membrane is inherently impermeable to large, hydrophilic molecules. While conventional small-molecule drugs also suffer from short circulation half-lives and off-target in...